peanut allergy - FDA approves new drug

The FDA has approved the first drug to treat peanut allergies in children and teens. This condition affects almost a million kids in the US alone.

By: IANS | | Updated: February 4, 2020 8:50 am

Peanut allergy affects approximately one million children in the US and only one out of five of these children will outgrow their allergy. @Shutterstock

The US Food and Drug Administration (FDA) has approved the first drug to treat peanut allergies in children and teens. Treatment with the drug, Palforzia, can be used for children between 4 and 17 years old with a confirmed diagnosis of peanut allergy, the FDA said in a statement. The drug is designed to minimize the incidence and severity of a child’s allergic reaction to peanuts, as even a small amount of exposure can be harmful to children with the allergy.

The powder is emptied from the capsules or sachet and mixed with a small amount of semisolid food — such as applesauce, yogurt, or pudding. The effectiveness of Palforzia is supported by a randomized, double-blind, placebo-controlled study conducted in the US, Canada and Europe in approximately 500 peanut-allergic individuals.

Published : February 4, 2020 8:49 am | Updated:February 4, 2020 8:50 am

Read Disclaimer

Heart disease: Reduce your risk with a plant-based diet

Menopause may increase your risk of heart disease

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Heart disease: Reduce your risk with a plant-based diet

Menopause may increase your risk of heart disease

About The health Site

Useful Links